What is Optibrand?
Optibrand is at the forefront of developing patented technology for the automated capture of retinal images, primarily through its innovative RetCheck Software. This advanced imaging solution is designed for broad applicability across human health, agriculture, and veterinary services. Its core function is to facilitate early disease detection, enhance food safety protocols, and streamline animal identification processes. The technology's emphasis on user-friendliness, cost-effectiveness, and adaptability for artificial intelligence systems underscores Optibrand's commitment to improving health outcomes and traceability in critical sectors.
How much funding has Optibrand raised?
Optibrand has raised a total of $20K across 1 funding round:
Debt
$20K
Debt (2021): $20K with participation from PPP
Key Investors in Optibrand
PPP
Public-Private Partnership
What's next for Optibrand?
With the infusion of substantial expansion capital, Optibrand is poised to scale its operations and further refine its AI-integrated imaging solutions. The company's strategic focus on diverse markets, from human diagnostics to agricultural and veterinary applications, suggests a roadmap for enhanced product development and market reach. This latest financing round is expected to fuel research and development initiatives, bolster sales and marketing efforts, and potentially expand its global footprint, solidifying its position as a key player in the specialized imaging technology sector.
See full Optibrand company page
